Upgrade to SI Premium - Free Trial

Abbott Labs (ABT) PT Lowered to $120 at Benchmark on Updated Guidance

April 17, 2026 6:54 AM
Benchmark analyst Bruce D. Jackson lowered the price target on Abbott Labs (NYSE: ABT) to $120.00 (from $145.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change